Email Updates

Search form

You are here

27 MAY 2016 VOLUME 17 ISSUE 21

Media Coverage

  • The findings from a Massachusetts General Hospital-based research team suggest that ART alone is not sufficient to reduce the elevated arterial inflammation that appears to contribute to the increased risk of cardiovascular disease in HIV-infected individuals.

    May 25, 2016
    Science Daily
  • The clinical trial at the Kirby Institute in Australia will test the new HIV prevention drug - pre-exposure prophylaxis (PrEP). While PrEP is not yet listed on the Pharmaceutical Benefits Scheme, one of the drug's brand, Truvada, has received a license from the Therapeutic Goods Administration. Professor Sharon Lewin from the Melbourne-based Doherty Institute expressed hopes that the NSW trial will help bring the new HIV drug to more Australians.

    May 24, 2016
    Tech Times
  • The fight against [HIV, TB, and malaria] is more important than ever in a world increasingly affected by natural disasters, conflict and economic crises... This new reality is why the Global Fund has prioritized challenging operating environments... The only way to maximize the impact of our investments and end these epidemics is by reaching everyone.

    May 24, 2016
    General
    Huffington Post
  • There has been a long-term decline in condom use by American gay men, researchers from CDC report in AIDS [and] cannot be explained by serosorting or other seroadaptive behaviours. Moreover condom use began to fall long before PrEP became available. The survey data were collected in 2005, 2008, 2011 and 2014 in 21 American cities as part of the National HIV Behavioral Surveillance.

    May 24, 2016
    aidsmap
  • Everybody is talking about how best to reform the WHO, arguably the best vehicle for coordinating the ever-changing global health agenda. But a new election process using secret ballots for appointing the next director-general is hardly a promising start.

    May 23, 2016
    General
    Humanosphere
  • About 125 million people are affected by crises. A quarter of those people are female and of reproductive age – and women are 14 times more likely than men to die in a crisis. On Monday global thinkers, activists and politicians will come together for the world humanitarian summit in Istanbul to tackle some of these issues. It’s time for them and us to act as the world faces the largest refugee crisis since the second world war.

    May 22, 2016
    General
    Guardian
  • Using gene editing technology, researchers at Temple University have, for the first time, successfully excised a segment of HIV-1 DNA from the genomes of living animals. The breakthrough, described online in Gene Therapy, is a critical step in development of a potentially curative strategy for HIV infection.

    May 19, 2016
    General
    Science Daily
  • The response to PrEP from NHS England has been frustratingly underwhelming - the journey to make PrEP available on the NHS has been dogged by delays, false starts, red tape and apathy... On 31 May, NHS England's specialised commissioning committee will meet to decide whether the previously agreed approval process for PrEP should continue. When that meeting happens, that group will effectively help decide on the future of the HIV epidemic in the UK.

    May 18, 2016
    Huffington Post
  • Microsoft co-founder Bill Gates will deliver the Nelson Mandela Annual Lecture at the University of Pretoria's Mamelodi campus on July 17‚ the eve of Mandela Day. The Nelson Mandela Foundation said Gates’ theme would be "Living Together".

    May 18, 2016
    General
    Times (South Africa)
  • In light of heavy criticism of the World Health Organization's handling of the Ebola outbreak, the election process for the next director general will be under intense scrutiny, say experts in a new article. In The BMJ, Devi Sridhar and colleagues outline the key questions on epidemic preparedness for prospective candidates.

    May 18, 2016
    General
    Science Daily
  • Scientists at the US Military HIV Research Program have enrolled and intensively followed a cohort of high-risk individuals, tracking their HIV status and characterizing the disease through the acute stages of HIV infection. Acute HIV infection contributes significantly to HIV transmission and may be important for intervention strategies seeking to reduce incidence and achieve a functional cure.

    May 18, 2016
    General
    Science Daily
  • New data released in ECDC's Annual Epidemiological report show that since 2010, overall syphilis rates have been going up across Europe, particularly among men. In 2014, the reported syphilis numbers were six times higher in men than in women. Almost two-thirds of the syphilis cases reported with information on transmission category were recorded in men who have sex with men.

    May 18, 2016
    General
    Science Daily
  • A small number of patients infected by HIV spontaneously control viral replication without antiretroviral therapy, and do not develop the disease. The ability of these rare patients, known as 'HIV controllers,' to suppress HIV replication appears to be down to a highly effective immune response. Scientists observed that CD4+ T immune cells in these patients were capable of recognizing tiny quantities of the virus.

    May 18, 2016
    General
    Science Daily

Published Research

Announcements